About this trial

This study is intended to include 3000 diabetic patients in our hospital to collect complete medical history data, comprehensively improve the screening of diabetic complications and cardiovascular and cerebrovascular risk assessment.

Eligibility criteria

Qualifiers

Diabetic symptoms with: plasma glucose level at any time ≥11.1mmol/ L (200mg/ dL), or Fasting plasma glucose level ≥7.0mmol/ L (126mg/ dL), or plasma glucose level ≥11.1mmol/ L (200ng/ dL) for 2 h in OGTT test, or HbA1c ≥6.5%; Or those without typical symptoms should repeated the tests in another day.

Han Chinese.

Willingness to participate.

Disqualifiers

Secondary diabetes.

Participants in other clinical trials.

Trial design

Treatments tested in this trial

  • no intervention

Treatment groups

3,000 Participants
are divided into 1 treatment group

Locations

1
Second Affiliated Hospital, School of Medicine, Zhejiang University310009, HangzhouZhejiang, China

Sponsors and collaborators

Second Affiliated Hospital, School of Medicine, Zhejiang University

Lead sponsor